There is now solid evidence that KRAS mutations are quite common and their worldwide frequency is 40–60% in CRC [6,8,9,44,45], with variations depending on the detection techniques, amount of cases included in the study groups or to the population characteristics. This evidence concerns the gene KRAS and colorectal carcinoma.